BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6220721)

  • 1. Medroxyprogesterone acetate improvement of the hepatic drug-metabolizing enzyme system in rats after chemical liver injury.
    Saarni HU; Stengård J; Kärki NT; Sotaniemi EA
    Biochem Pharmacol; 1983 Mar; 32(6):1075-81. PubMed ID: 6220721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of medroxyprogesterone acetate on hepatic glucose metabolism and microsomal enzyme activity in rats with normal and altered liver.
    Stengård JH; Saarni HU; Sotaniemi EA
    Pharmacology; 1984; 28(1):34-41. PubMed ID: 6322213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of medroxyprogesterone acetate and hepatic drug metabolism activity.
    Rautio A; Saarni HU; Arranto AJ; Stengård JH; Kärki NT; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):305-8. PubMed ID: 3158039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone acetate and phenobarbital induce NADPH producing enzyme activities in rats with a chemical liver injury.
    Stengård JH; Saarni HU; Stenbäck F; Keinänen K; Kärki NT; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):93-102. PubMed ID: 3001883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medroxyprogesterone acetate on liver collagen and drug metabolism in rats after chemical liver injury.
    Saarni HU; Savolainen ER; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):61-9. PubMed ID: 6316438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of liver cirrhosis with microsomal enzyme-inducing compound in the rat.
    Saarni HU; Arranto AJ; Rautio A; Sotaniemi EA
    J Hepatol; 1985; 1(5):501-11. PubMed ID: 2932501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of medroxyprogesterone acetate on the hepatic drug-metabolizing enzymes in normal and protein-deficient female rats.
    Nagpal JP; Khanduja KL; Sharma RR; Majumdar S; Singh R; Gupta MP; Dogra SC
    Biochem Med; 1985 Aug; 34(1):11-6. PubMed ID: 2932101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of hepatic changes produced by medroxyprogesterone acetate in the rat.
    Saarni HU
    Gen Pharmacol; 1986; 17(1):25-9. PubMed ID: 2936647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of phenobarbital and medroxyprogesterone acetate on drug and glucose metabolism in rats with chemical liver injury.
    Stengård JH
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):67-76. PubMed ID: 6239340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medroxyprogesterone acetate on steroid reductases in rat liver.
    Graef V; Golf SW; Ziemendorff Y
    Arzneimittelforschung; 1985; 35(9):1451-3. PubMed ID: 2935162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medroxyprogesterone induced changes in rat liver. A light and electron microscopic study.
    Arranto AJ
    Pathol Res Pract; 1983 Mar; 176(2-4):115-24. PubMed ID: 6222294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate (MPA) enhances liver NADPH-generating enzyme activities in normal rats.
    Stengård JH; Saarni HU; Sotaniemi EA
    Gen Pharmacol; 1988; 19(3):377-80. PubMed ID: 2970986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo protection by protein A of hepatic microsomal mixed function oxidase system of CCl4-administered rats.
    Srivastava SP; Singh KP; Saxena AK; Seth PK; Ray PK
    Biochem Pharmacol; 1987 Dec; 36(23):4055-8. PubMed ID: 3689437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
    Smith BJ; Hu JK; Schwecke WP
    Drug Chem Toxicol; 1998 Aug; 21(3):291-303. PubMed ID: 9706462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of gomisin A, a lignan component of Schizandra fruits, on experimental liver injuries and liver microsomal drug-metabolizing enzymes].
    Takeda S; Maemura S; Sudo K; Kase Y; Arai I; Ohkura Y; Funo S; Fujii Y; Aburada M; Hosoya E
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):169-87. PubMed ID: 3699630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
    Hietanen E; Ahotupa M; Heikelä A; Laitinen M
    Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medroxyprogesterone acetate does not induce antipyrine clearance and only weakly increases alpha 1-acid glycoprotein in beagle dogs.
    Abramson FP; Moore CF; Hill MD
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):65-78. PubMed ID: 2944196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chlorpromazine hydrochloride on carcinogen-metabolizing enzymes: liver microsomal dimethylnitrosamine demethylase, 4-dimethylaminoazobenzene reductase, and aryl hydrocarbon hydroxylase.
    Mostafa MH; Weisburger EK
    J Natl Cancer Inst; 1980 Apr; 64(4):925-9. PubMed ID: 6767870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of phenobarbital and 3,4-benzypyrene on microsomal cytochrome P-450 and NADPH-cytochrome C reductase in regenerating rat liver after partial hepatectomy or chemical injury.
    Katz DI; Stenger RJ; Johnson EA; Datta RK; Rice J
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):180-91. PubMed ID: 413503
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme.
    Kurata N; Yoshida T; Kuroiwa Y; Masuko T; Hashimoto Y
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):161-79. PubMed ID: 2587838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.